Depression and Anxiety Trial, Recruiting NCT06725134 Sponsor: University of Michigan Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06725134
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 4 and 12 years old
  • Children who are generally healthy, with no serious medical conditions
  • Children who are already scheduled for at least two dental appointments that will require a numbing injection (local anesthesia)
  • A parent or legal guardian must provide written consent for the child to take part
  • Children aged 4–9 years need to give verbal agreement to participate, while children aged 10–12 years need to provide written agreement

Who may not be able to join:

  • Children who are known to be allergic to dogs or animal fur/dander
  • Children who are afraid of or have a phobia of dogs
  • Children with a behavioural condition that may affect how they respond to having a therapy dog present (confirm with trial site)
  • Children who have previously had a dental procedure involving a numbing injection while a therapy dog was present
  • Children with a medical condition that could affect their heart rate, blood pressure, or other vital signs independently of the dental procedure (for example, a heart condition)
  • Cases where a parent or guardian feels uncomfortable having a therapy dog present during the procedure
  • Children whose behaviour during dental examinations has been rated as "Definitely Negative" using a standard dental behaviour scale called the Frankl Scale (rated Frankl 1)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: James R. Boynton, DDS, MS, University of Michigan

Phone: 734-764-1523

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Behavior (Face, Legs, Activity, Cry, and Consolability scale)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov